- Área de investigación
-
- Ciencia y Tecnologías Químicas
- Instituto
-
- INSTITUTO DE QUIMICA ORGANICA GENERAL
- Importe
- 9.221,75 €
Development of innovative antagonists against breast tumours of poor prognosis using a targeted protein degradation approach
Integrantes: